| 000 | 01631 a2200493 4500 | ||
|---|---|---|---|
| 005 | 20250517203149.0 | ||
| 264 | 0 | _c20190221 | |
| 008 | 201902s 0 0 eng d | ||
| 022 | _a1468-1331 | ||
| 024 | 7 |
_a10.1111/ene.13606 _2doi |
|
| 040 |
_aNLM _beng _cNLM |
||
| 100 | 1 | _aCirillo, E | |
| 245 | 0 | 0 |
_aMinimum effective betamethasone dosage on the neurological phenotype in patients with ataxia-telangiectasia: a multicenter observer-blind study. _h[electronic resource] |
| 260 |
_bEuropean journal of neurology _c06 2018 |
||
| 300 |
_a833-840 p. _bdigital |
||
| 500 | _aPublication Type: Journal Article; Multicenter Study; Research Support, Non-U.S. Gov't | ||
| 650 | 0 | 4 | _aAdolescent |
| 650 | 0 | 4 |
_aAtaxia Telangiectasia _xdrug therapy |
| 650 | 0 | 4 |
_aBetamethasone _xadministration & dosage |
| 650 | 0 | 4 | _aChild |
| 650 | 0 | 4 | _aChild, Preschool |
| 650 | 0 | 4 | _aDose-Response Relationship, Drug |
| 650 | 0 | 4 | _aFemale |
| 650 | 0 | 4 |
_aGlucocorticoids _xadministration & dosage |
| 650 | 0 | 4 | _aHumans |
| 650 | 0 | 4 | _aMale |
| 650 | 0 | 4 | _aPhenotype |
| 650 | 0 | 4 | _aQuality of Life |
| 650 | 0 | 4 | _aTreatment Outcome |
| 650 | 0 | 4 | _aYoung Adult |
| 700 | 1 | _aDel Giudice, E | |
| 700 | 1 | _aMicheli, R | |
| 700 | 1 | _aCappellari, A M | |
| 700 | 1 | _aSoresina, A | |
| 700 | 1 | _aDellepiane, R M | |
| 700 | 1 | _aPietrogrande, M C | |
| 700 | 1 | _aDell'Era, L | |
| 700 | 1 | _aSpecchia, F | |
| 700 | 1 | _aPession, A | |
| 700 | 1 | _aPlebani, A | |
| 700 | 1 | _aPignata, C | |
| 773 | 0 |
_tEuropean journal of neurology _gvol. 25 _gno. 6 _gp. 833-840 |
|
| 856 | 4 | 0 |
_uhttps://doi.org/10.1111/ene.13606 _zAvailable from publisher's website |
| 999 |
_c28130520 _d28130520 |
||